BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16884603)

  • 1. NICE Health Technology Appraisal Programme.
    Burchell M; Ruiz F; Barnett D
    Ann R Coll Surg Engl; 2005 Jul; 87(4):283-4. PubMed ID: 16884603
    [No Abstract]   [Full Text] [Related]  

  • 2. The Type and Impact of Evidence Review Group Exploratory Analyses in the NICE Single Technology Appraisal Process.
    Carroll C; Kaltenthaler E; Hill-McManus D; Scope A; Holmes M; Rice S; Rose M; Tappenden P; Woolacott N
    Value Health; 2017 Jun; 20(6):785-791. PubMed ID: 28577696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives on "early dialogue" between a manufacturer and health technology assessment agencies.
    Geisler BP
    Value Health; 2011 Jun; 14(4):607. PubMed ID: 21669386
    [No Abstract]   [Full Text] [Related]  

  • 4. Health technology assessment in Europe.
    Kristensen FB
    Scand J Public Health; 2009 Jun; 37(4):335-9. PubMed ID: 19493989
    [No Abstract]   [Full Text] [Related]  

  • 5. Written in the stars. Introducing our five-star rating system.
    Health Devices; 2010 Mar; 39(3):73. PubMed ID: 21309267
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent amendments to NICE's value-based assessment of health technologies: implicitly inequitable?
    Paulden M
    Expert Rev Pharmacoecon Outcomes Res; 2017 Jun; 17(3):239-242. PubMed ID: 28490259
    [No Abstract]   [Full Text] [Related]  

  • 7. Health technology assessment.
    Hailey D
    Singapore Med J; 2006 Mar; 47(3):187-92; quiz 193. PubMed ID: 16518551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence Review Group approaches to the critical appraisal of manufacturer submissions for the NICE STA process: a mapping study and thematic analysis.
    Kaltenthaler E; Boland A; Carroll C; Dickson R; Fitzgerald P; Papaioannou D
    Health Technol Assess; 2011 May; 15(22):1-82, iii-iv. PubMed ID: 21561569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data rich, information poor.
    Drug Ther Bull; 2013 Sep; 51(9):97. PubMed ID: 24009316
    [No Abstract]   [Full Text] [Related]  

  • 10. Health technology assessment (HTA) increasingly important in spine research.
    van Tulder M
    Eur Spine J; 2011 Jul; 20(7):999-1000. PubMed ID: 21720729
    [No Abstract]   [Full Text] [Related]  

  • 11. Health technology assessment programme.
    J Med Screen; 2008; 15(1):52-4. PubMed ID: 18416961
    [No Abstract]   [Full Text] [Related]  

  • 12. Biosimilars: evidential standards for health technology assessment.
    Hughes DA
    Clin Pharmacol Ther; 2010 Mar; 87(3):257-61. PubMed ID: 20160743
    [No Abstract]   [Full Text] [Related]  

  • 13. [Health technology assessment: research methodology].
    Nita ME; Secoli SR; Nobre M; Ono-Nita SK
    Arq Gastroenterol; 2009; 46(4):252-5. PubMed ID: 20232002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The need for Health Technology Assessments of PET.
    Van Tinteren H; Hoekstra OS; Boers M
    Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1438-9; author reply 1439. PubMed ID: 12898206
    [No Abstract]   [Full Text] [Related]  

  • 15. The failings of NICE. Reply from chairman of NICE.
    Rawlins MD
    BMJ; 2001 Feb; 322(7284):489. PubMed ID: 11222437
    [No Abstract]   [Full Text] [Related]  

  • 16. Health technology assessment of PET in oncology: re Eur J Nucl Med Mol Imaging 2003; 30:637-641.
    Kristensen FB; Adams E; Briones E; Coburn D; Facey K; Hansen NW; Hoeksema J; Mørland B
    Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):295-7; author reply 297-8; discussion 298. PubMed ID: 15129712
    [No Abstract]   [Full Text] [Related]  

  • 17. Single technology appraisals by NICE: are they delivering faster guidance to the NHS?
    Barham L
    Pharmacoeconomics; 2008; 26(12):1037-43. PubMed ID: 19014204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A little learning: reflections on 10 years of NICE technology appraisals.
    Longson CM
    Health Econ; 2012 Jan; 21(1):30-2. PubMed ID: 22147626
    [No Abstract]   [Full Text] [Related]  

  • 19. Health technology assessments and innovation.
    Tucker J; Boone K; Fedak P
    Nat Biotechnol; 2013 Nov; 31(11):970-1. PubMed ID: 24213766
    [No Abstract]   [Full Text] [Related]  

  • 20. Setting the research agenda for women and children: the role of Health Technology Assessment.
    Choonara I; Kenny T
    Arch Dis Child; 2013 Aug; 98(8):574-5. PubMed ID: 23749947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.